Overview
Vishal Vashistha is a Hematologist in Albuquerque, New Mexico. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adenoid Cystic Carcinoma, and Bladder Cancer.
His clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1501 San Pedro Dr SE, Albuquerque, NM 87108
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Cancer Center Pharmacy
Leslie Andritsos is a Hematologist in Albuquerque, New Mexico. Dr. Andritsos is highly rated in 24 conditions, according to our data. Her top areas of expertise are Hairy Cell Leukemia (HCL), Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Splenectomy.
UNM Medical Group Inc
Ian Rabinowitz is a Hematologist in Albuquerque, New Mexico. Dr. Rabinowitz is highly rated in 31 conditions, according to our data. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Ependymoma, Atypical Teratoid Rhabdoid Tumor (ATRT), and Neuroepithelioma.
Presbyterian Healthcare Services
Mitchell Binder is a Hematologist in Albuquerque, New Mexico. Dr. Binder is highly rated in 20 conditions, according to our data. His top areas of expertise are EGFR Positive Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Large-Cell Lung Carcinoma.
Frequently Asked Questions about Dr. Vishal Vashistha
How do I make an appointment with Dr. Vishal Vashistha?
You can book an appointment with Dr. Vishal Vashistha by calling their office at 505-265-1711. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Vishal Vashistha a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vishal Vashistha is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Vishal Vashistha specialize in?
While Dr. Vishal Vashistha is a Hematology, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Adenoid Cystic Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Vishal Vashistha participate in research or clinical trials?
Yes. Dr. Vishal Vashistha has published 32 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Vishal Vashistha's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adenoid Cystic CarcinomaDr. Vashistha isExperienced. Learn about Adenoid Cystic Carcinoma.
- Bladder CancerDr. Vashistha isExperienced. Learn about Bladder Cancer.
- Familial Prostate CancerDr. Vashistha isExperienced. Learn about Familial Prostate Cancer.
- Lung AdenocarcinomaDr. Vashistha isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Vashistha isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Vashistha isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).